Sumitomo Chemical India Limited
Quality (74/100) does the heavy lifting; valuation (27/100) is the drag.
Fair valueOvervaluedStocksWizard rates Sumitomo Chemical India Limited a Hold, scoring 45/100 on our blended model. On 41.0x trailing earnings it sits roughly in line with the Chemicals median of about 41.0x. The price is about 21% below its 52-week high of ₹647.14 and 40% above the low of ₹363.57. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 3/9. The average analyst target of ₹555.33 implies about 9% upside across 9 analysts. It clears 9 of 13 investability checks, with durability 74, valuation 46 and momentum 68 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹304.89.
Analyst views
1-year price
EOD · 2026-07-3152-week range
-21.15% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Hold45Piotroski F-score 3/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Pass: ROE above 15%: 17.2%
- Pass: Low debt (D/E < 0.5): 0.02x
- Pass: Positive free cash flow
- Fail: Revenue growth > 10%: 1%
- Pass: Earnings growing: 12%
- Pass: Net margin ≥ 10%: 16.8%
- Pass: Current ratio > 1.5: 3.44
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Pass: Above 200-day average
- Pass: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 13.84
- Fail: Piotroski ≥ 7: 3/9
Quarterly results
Annual financials
Shareholding
- Promoter75.5%
- Institutions8.9%
- Public & other15.6%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Lightly leveraged balance sheet.
- Healthy profit margin (16.8%).
- Financially solid — Altman Z 13.84.
Bear case
Weaknesses
- Weak Piotroski score (3/9).
Threats
- Trades ~25% above our estimated fair value.
About Sumitomo Chemical India Limited
Sumitomo Chemical India Limited manufactures and sells insecticides for household and public health applications, agricultural pesticides, and animal nutrition products across India and international markets. Its product portfolio includes crop protection chemicals such as insecticides, herbicides, fungicides, and miticides, along with plant nutrition, plant growth regulators, fumigants, rodenticides, weedicides, and biological products.
Sumitomo Chemical India Limited — frequently asked questions
Is Sumitomo Chemical India Limited a buy, hold or sell?
StocksWizard currently rates Sumitomo Chemical India Limited (SUMICHEM) a Hold, based on a blended score of 45/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Sumitomo Chemical India Limited's fair value?
Our blended DCF and relative-valuation model estimates Sumitomo Chemical India Limited's fair value at about ₹381.11, versus a current price of ₹510.3 — roughly 25% downside. On that basis the stock looks overvalued by 25%.
Is Sumitomo Chemical India Limited financially healthy?
Sumitomo Chemical India Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 3/9.
How has Sumitomo Chemical India Limited's share price performed?
Sumitomo Chemical India Limited is up 7% over three months, and last traded at ₹510.3. Past performance doesn't predict future returns.
More in Chemicals
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.